Post-approval studies (Phase 4)UnknownNCT00838019What this trial is testingIntrabone Cord Blood TransplantationWho this might be right forHematological Malignancies Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT00002619What this trial is testingChemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem TumorsWho this might be right forBrain and Central Nervous System Tumors NYU Langone Health 60
Not applicableLooking for participantsNCT06509945What this trial is testingAllo-PBSCT as the First-line Treatment for Patients With the High-risk PTCLWho this might be right forPeripheral T Cell Lymphoma Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)WithdrawnNCT00972101What this trial is testingInfusion of Expanded Cord Blood T CellsWho this might be right forStem Cell TransplantationLeukemiaLymphoma+1 more M.D. Anderson Cancer Center
Not applicableStudy completedNCT03959007What this trial is testingImpact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood DiseasesWho this might be right forAcute LeukemiaHematopoietic Stem Cell Transplantation (SCT)Aplasia University Hospital, Lille 70
Testing effectiveness (Phase 2)Study completedNCT02405364What this trial is testingFront-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone InductionWho this might be right forMultiple Myeloma University Hospital, Toulouse 46
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Looking for participantsNCT02605421What this trial is testingMyeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaWho this might be right forNeuroblastoma Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT00223730What this trial is testingChemotherapy Toxicity Reduction Via Urea Cycle SupportWho this might be right forCancer Vanderbilt University 100
Testing effectiveness (Phase 2)Study completedNCT00116467What this trial is testingVaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia Cell Genesys 55
Testing effectiveness (Phase 2)WithdrawnNCT03602898What this trial is testingComparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic Leukemia+10 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Large-scale testing (Phase 3)Ended earlyNCT02145598What this trial is testingTreatment Optimization in Patients With Untreated Multiple MyelomaWho this might be right forMultiple Myeloma Dr. med. Lars-Olof Muegge 85
Large-scale testing (Phase 3)Study completedNCT00495287What this trial is testingA Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)Who this might be right forAcute Myelogenous Leukemia Northern Italy Leukemia Group 573
Not applicableStudy completedNCT05421299What this trial is testingAssess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and MethotrexateWho this might be right forStem Cell Transplantation Bristol-Myers Squibb 378
Early research (Phase 1)UnknownNCT00008021What this trial is testingMonoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of California, Davis
Large-scale testing (Phase 3)UnknownNCT00415987What this trial is testingHematopoietic Stem Cell Transplantation in MyelomaWho this might be right forMultiple Myeloma Azienda Ospedaliera San Giovanni Battista
Not applicableLooking for participantsNCT06698887What this trial is testingEvaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in KoreaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)Ended earlyNCT02504619What this trial is testingAllogeneic SCT of CordIn™, in Patients With HemoglobinopathiesWho this might be right forSickle Cell DiseaseThalassemia Gamida Cell ltd 1